Barclays PLC Organogenesis Holdings Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Barclays PLC holds 94,809 shares of ORGO stock, worth $289,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,809

Previous 94,809 -0.0%

Holding current value

$289,167

Previous $271,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$2.42 - $3.24 $164,209 - $219,850	67,855 Added 251.74%	94,809 $271,000
Q2 2024 Aug 14, 2024	SELL	$2.28 - $3.03 $50,857 - $67,587	-22,306 Reduced 45.28%	26,954 $76,000
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $122,518 - $210,769	-46,942 Reduced 48.8%	49,260 $140,000
Q4 2023 Feb 15, 2024	BUY	$1.97 - $4.21 $139,724 - $298,598	70,926 Added 280.61%	96,202 $394,000
Q3 2023 Nov 07, 2023	BUY	$2.34 - $4.43 $26,404 - $49,988	11,284 Added 80.65%	25,276 $80,000
Q2 2023 Aug 03, 2023	SELL	$1.9 - $4.3 $168,788 - $381,994	-88,836 Reduced 86.39%	13,992 $47,000
Q1 2023 May 04, 2023	SELL	$1.89 - $2.93 $7,490 - $11,611	-3,963 Reduced 3.71%	102,828 $218,000
Q4 2022 Feb 13, 2023	BUY	$2.48 - $3.43 $166,663 - $230,506	67,203 Added 169.76%	106,791 $288,000
Q3 2022 Nov 03, 2022	BUY	$3.14 - $6.43 $61,380 - $125,693	19,548 Added 97.54%	39,588 $129,000
Q2 2022 Aug 12, 2022	SELL	$4.74 - $8.15 $151,874 - $261,134	-32,041 Reduced 61.52%	20,040 $98,000
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $42,585 - $62,989	-6,582 Reduced 11.22%	52,081 $397,000
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $88,089 - $131,841	9,766 Added 19.97%	58,663 $543,000
Q3 2021 Nov 09, 2021	BUY	$13.71 - $17.18 $155,073 - $194,322	11,311 Added 30.09%	48,897 $696,000
Q2 2021 Aug 13, 2021	BUY	$14.92 - $23.23 $222,919 - $347,079	14,941 Added 65.98%	37,586 $626,000
Q1 2021 May 13, 2021	BUY	$7.33 - $21.06 $69,656 - $200,133	9,503 Added 72.31%	22,645 $413,000
Q4 2020 Feb 11, 2021	SELL	$3.63 - $7.53 $5,292 - $10,978	-1,458 Reduced 9.99%	13,142 $99,000
Q3 2020 Nov 12, 2020	SELL	$3.29 - $4.58 $6,076 - $8,459	-1,847 Reduced 11.23%	14,600 $56,000
Q2 2020 Aug 12, 2020	BUY	$2.86 - $4.61 $20,451 - $32,966	7,151 Added 76.93%	16,447 $64,000
Q1 2020 May 13, 2020	SELL	$2.92 - $5.31 $20,521 - $37,318	-7,028 Reduced 43.05%	9,296 $30,000
Q4 2019 Feb 10, 2020	BUY	$4.7 - $8.11 $52,311 - $90,264	11,130 Added 214.29%	16,324 $79,000
Q3 2019 Nov 14, 2019	SELL	$3.57 - $8.09 $5,701 - $12,919	-1,597 Reduced 23.52%	5,194 $34,000
Q2 2019 Aug 14, 2019	SELL	$6.58 - $8.69 $26,570 - $35,090	-4,038 Reduced 37.29%	6,791 $52,000
Q1 2019 May 15, 2019	BUY	$7.05 - $150.0 $76,344 - $1.62 Million	10,829 New	10,829 $81,000

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

63.2M

Call Options Held

25K

Put Options Held

23.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $399M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account